CCM
BIIB icon

Crabel Capital Management’s Biogen BIIB Stock Holding History

Crabel Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-781
Closed -$232K – 24
2019
Q4 		$232K Sell
781
-399
-34% -$111K 0.09% 172
2019
Q3 		$275K Buy
+1,180
New +$275K 0.16% 127

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Crabel Capital Management's BIIB Position: Q1 2020 in Review

Crabel Capital Management sold out of Biogen (BIIB) in Q1 2020, closing a stake of 781 shares — an estimated $232K sold.

Crabel Capital Management first reported a position in BIIB in Q3 2019 and held it in 2 quarters. The position peaked at $275K in Q3 2019. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Crabel Capital Management reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Crabel Capital Management sold 781 Biogen shares in Q1 2020, an estimated $232K.
  • Crabel Capital Management first reported a position in Biogen in Q3 2019 and held it in 2 quarters.
  • Crabel Capital Management's Biogen position peaked at $275K in Q3 2019.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Crabel Capital Management's 13F filing for Q1 2020, filed 7 May 2020.